19. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950 18. [IF=3.943] Yu-Nan Lu et al."Arctigenin exhibits hepatoprotective activity in Toxoplasma gondii-infected host through HMGB1/TLR4/NF-κB pathway."Int Immunopharmacol. 2020 Jul;84:106539 17. [IF=3.943] Jia-Hui Cheng et al."Arctigenin ameliorates depression-like behaviors in Toxoplasma gondii-infected intermediate hosts via the TLR4/NF-κB and TNFR1/NF-κB signaling pathways."Int Immunopharmacol. 2020 May;82:106302 16. [IF=0] Tingting Feng et al."Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy."Oncotarget. 2017 Jan 3; 8(1): 329–344 15. [IF=3.417] Qiuyue Huang et al."Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A."Oncol Rep. 2017 Jul;38(1):598-606 14. [IF=4.077] Yuru Du et al."Repeated arctigenin treatment produces antidepressant- and anxiolytic-like effects in mice."Brain Res Bull. 2019 Mar;146:79 13. [IF=4.411] Jifeng Gu et al."Application of High-Performance Liquid Chromatography Coupled with Linear Ion Trap Quadrupole Orbitrap Mass Spectrometry for Qualitative and Quantitative Assessment of Shejin-Liyan Granule Supplements."Molecules. 2018 Apr;23(4):884 12. [IF=5.64] Wu Dousheng et al."Oleanolic Acid Induces the Type III Secretion System of Ralstonia solanacearum."Front Microbiol. 2015 Dec;0:1466 11. Valkó, Klára. "Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution." Journal of chromatography A 1037.1-2 (2004): 299-310.https://doi.org/10.1016/j.chroma.2003.10.084 10. Valkó, Klára. "Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution." Journal of chromatography A 1037.1-2 (2004): 299-310.https://doi.org/10.1016/j.chroma.2003.10.084 9. Cheng, Jia-Hui, et al. "Arctigenin ameliorates depression-like behaviors in Toxoplasma gondii-infected intermediate hosts via the TLR4/NF-κB and TNFR1/NF-κB signaling pathways." International immunopharmacology 82 (2020): 106302.https://doi.org/10.1016/j.i 8. Lu, Yu-Nan, et al. "Arctigenin exhibits hepatoprotective activity in Toxoplasma gondii-infected host through HMGB1/TLR4/NF-κB pathway." International immunopharmacology 84 (2020): 106539.https://doi.org/10.1016/j.intimp.2020.106539 7. Feng, Tingting, et al. "Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy." Oncotarget 8.1 (2017): 329.https://dx.doi.org/10.18632%2Foncotarget.13393 6. Huang, Qiuyue, et al. "Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A." Oncology reports 38.1 (2017): 598-606.https://doi.org/10.3892/or.2017.5667 5. Yuru Du, Wenjing Li, Yiming Li, Juxiang Yang, Xinhao Wang, Shuo Yin, Xi Wang, Omar Israel Velez de-la-Paz, Yuan Gao, Haiying Chen, Xi Yin, Haishui Shi, Repeated arctigenin treatment produces antidepressant- and anxiolytic-like effects in mice, Brain Resear 4. 袁曉寧, 馬文靜, 孫智婷,等. 牛蒡苷元下調(diào)CIP2A抑制三陰性乳腺癌轉(zhuǎn)移的作用及機(jī)制研究[J]. 湖北醫(yī)藥學(xué)院學(xué)報(bào), 2017(05):391-396. 3. 陸明, 姬飛虹, 張林杰. 牛蒡子苷元對(duì)小鼠脾細(xì)胞增殖的影響及相關(guān)機(jī)制[J]. 安徽醫(yī)科大學(xué)學(xué)報(bào), 2014(6):726-730. 2. 狄恒建, 李松, 郭青,等. 炒牛蒡子配方顆粒HPLC指紋圖譜研究[J]. 藥學(xué)與臨床研究, 2013, 021(006):637-639. 1. 許佳欣,佘家軍,楊銳,向雨晨,司淵,劉瑩.天然藥物牛蒡苷元直接靶向STAT3抑制三陰性乳腺癌的分子對(duì)接及分子動(dòng)力學(xué)研究[J].湖北醫(yī)藥學(xué)院學(xué)報(bào),2019,38(01):1-9.